Quantcast

Posts related to ‘prostate cancer’

Dendreon Shares Losing House Committee Hope (DNDN)

Posted: February 13, 2008 at 3:34 pm

CNBC's Mike Huckman just announced what is going to be a disappointment for Dendreon (NASDAQ: DNDN) holders, and that may be an understatement.  The House Committee will not be forcing ...
Read Full Story »

Dendreon Sets Stage for 2008 for PROVENGE

Posted: October 23, 2007 at 6:55 am

Dendreon (NASDAQ:DNDN) has issued a press release noting that it has completed its target enrollment of 500 patients in phase III IMPACT study of PROVENGE for advanced prostate cancer.  It ...
Read Full Story »